ELUCID'S STORY

Accurate clinical insights based on biology

Patients with known or suspected cardiovascular disease are at risk for deadly events like heart attacks and strokes. A peek deep inside arterial walls can be life-saving. And now it’s possible. Elucid is the first and only non-invasive image analysis software that combines CT angiography and histology to quantify the amount of arterial plaque to help physicians predict the risk of heart attack or stroke well before they arise.

Based on thousands of real tissue samples and images, the system’s patented algorithms quantify the plaque and help inform risk so physicians can determine patient-specific treatments. A powerful tool backed by more than 40 years of clinical research, Elucid’s software has been shown to be a significantly better predictor of heart attack and stroke than legacy care pathways. (Van Assen, M., et al., Automated plaque analysis for the prognostication of major adverse cardiac events. European Society of Radiology, 2019; Lal B.K., et al., Novel Application of Artificial Intelligence Algorithms to Develop a Predictive Model for Major Adverse Neurologic Events in Patients With Carotid Atherosclerosis. Journal of Vascular Surgery. July 2020. DOI: 10.1016/j.jvs.2020.04.306. Compared to current stenosis based guidelines.)